Herbas VPB

Print
EN | LT
LT - ETRASIMOD FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS
EN - ETRASIMOD FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/403 (2006.01)
A61P 1/00 (2018.01)
A61P 1/00 (2006.01)
C07D 209/94 (2013.01)
A61P 1/04 (2006.01)
A61P 1/04 (2018.01)
C07D 209/94 (2006.01)
A61K 31/404 (2013.01)
A61K 31/404 (2006.01)
A61K 9/2018 (2013.01)
A61K 9/20 (2006.01)
A61K 9/2054 (2013.01)
A61K 9/2059 (2013.01)
A61K 9/2013 (2013.01)
European patent
(11) Number of the document 4061358
(13) Kind of document T
(96) European patent application number 20888950.1
Date of filing the European patent application 2020-11-20
(97) Date of publication of the European application 2022-09-28
(45) Date of publication and mention of the grant of the patent 2025-05-28
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2020/061653
Date 2020-11-20
PCT application publication
(87) Number WO 2021/102357
Date 2021-05-27
Priority applications
(30) Number Date Country code
201962938008 P 2019-11-20 US
Inventors
(72)
KOMORI-OCCHICONE, Heather, Kiyomi , US
NGUYEN-CLEARY, Thai, Curtis , US
YU, Jin , US
Grantee
(73) Arena Pharmaceuticals, Inc. , 66 Hudson Boulevard East, New York, NY 10001-2192, US
Title
(54) ETRASIMOD FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS
  ETRASIMOD FOR USE IN THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS